Breast Cancer Clinical Trials in Pennsylvania

Showing 441-460 of 602 trials

Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity

NCT00886535

This study will be an open-label prospective observational trial designed to test associations between polymorphisms of candidate genes and tamoxifen. Pre- and post-menopausal women taking tamoxifen as standard therapy or chemopreventive therapy will be included in this study.

Breast CancerDuctal Carcinoma in Situ

Milton S. Hershey Medical Center41 participantsStarted Feb 2010

Hershey, Pennsylvania, United States

COMPLETEDPhase 337 miles

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

NCT01376349

RATIONALE: Dehydroepiandrosterone (DHEA) may help relieve vaginal symptoms in female cancer survivors. PURPOSE: This randomized phase III trial studies DHEA to see how well it works compared to placebo in treating postmenopausal cancer survivors with vaginal symptoms.

Breast CancerGynecologic Cancer

Alliance for Clinical Trials in Oncology464 participantsStarted Jul 2011

Scottsdale, Arizona, United States • Aurora, Colorado, United States • Boulder, Colorado, United States +277 more locations

Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Breast Cancer Trials in Other Cities

Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

Lapatinib and Trastuzumab With or Without Endocrine Therapy

MRI to Detect Breast Tumors in Women

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer

Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography

Other Conditions in Pennsylvania